T A B L E O F C O N T E N T S

A B S T R A C T
Background
Leg ulceration is a common, chronic, recurring condition. The estimated prevalence of leg ulcers in the UK population is 1.5 to 3 per 1000. Venous ulcers (also called stasis or varicose ulcers) comprise 80% to 85% of all leg ulcers. Electromagnetic therapy (EMT) is sometimes used as a treatment to assist the healing of chronic wounds such as venous leg ulcers.
Objectives
To assess the effects of EMT on the healing of venous leg ulcers.
Search methods
For this third update, we searched The Cochrane Wounds Group Specialised Register (searched 12 
Selection criteria
Randomised controlled trials comparing EMT with sham-EMT or other treatments.
Data collection and analysis
At least two review authors independently scrutinised search results and obtained full reports of potentially eligible studies for further assessment. We extracted and summarised details of eligible studies using a data extraction sheet, and made attempts to obtain missing data by contacting study authors. A second review author checked data extraction, and we resolved disagreements after discussion between review authors.
Main results
Three randomised controlled trials (RCTs) of variable quality involving 94 people were included in the original review; subsequent updates have identified no new trials. All the trials compared the use of EMT with sham-EMT. In the two trials that reported healing rates; one small trial (44 participants) reported that significantly more ulcers healed in the EMT group than the sham-EMT group however this result was not robust to different assumptions about the outcomes of participants who were lost to follow up. The second trial that reported numbers of ulcers healed found no significant difference in healing. The third trial was also small (31 participants) and reported significantly greater reductions in ulcer size in the EMT group however this result may have been influenced by differences in the prognostic profiles of the treatment groups.
Authors' conclusions
There is no high quality evidence that electromagnetic therapy increases the rate of healing of venous leg ulcers, and further research is needed.
P L A I N L A N G U A G E S U M M A R Y
Electromagnetic therapy (EMT) for treating venous leg ulcers
Venous leg ulcers (which appear as open sores) can be caused by a blockage or breakdown in the veins of the legs. Compression of the leg, using bandages or hosiery (stockings), can help heal most of these ulcers. Electromagnetic therapy is also sometimes offered. Electromagnetic therapy is not a form of radiation or heat, but uses an electromagnetic field to try to promote healing. This review of clinical trials concluded that there is no high quality evidence that electromagnetic therapy speeds the healing of venous leg ulcers.
B A C K G R O U N D Description of the condition
A leg ulcer is a common, chronic, recurring condition defined as the "loss of skin below the knee on the leg or foot, which takes more than six weeks to heal" (NHS CRD 1997). The estimated prevalence of leg ulcers within the UK population is 1.5 to 3 per 1000; however, prevalence increases with age, mounting to 20 per 1000 in people over 80 years old (NHS CRD 1997) , and is higher amongst women (Callam 1986) . Callam 1986 reported that 45% of people with leg ulcers in a Scottish study experienced episodes of ulceration for more than 10 years. Leg ulcers constitute a considerable cost to both the patient (Charles 1995) and the health service (Bosanquet 1992). Indeed, the economic cost of leg ulcers to the National Health Service (NHS) in the UK has been estimated at £400 million a year (Simon 2004). Venous ulcers (also known as stasis or varicose ulcers) constitute 80% to 85% of all leg ulcers (Simon 2004). These are caused by venous insufficiency which has been shown to be associated with increased hydrostatic pressure in the veins of the leg. The application of external compression reverses this and generally leads to the healing of the ulcers (O'Meara 2012). However, a significant proportion of ulcers do not heal with compression therapy and additional treatments are used for this group of people. (Stiller 1992) . A number of devices have been constructed to deliver either a continuous or a pulsed electromagnetic field (PEMF). PEMFs are produced with an 'on-off ' effect of pulsing current to produce field effects, which, it has been suggested, may influence tissue generation and cell proliferation, and thus may be useful for wound healing. The main advantage of PEMF compared with continuous fields is that the short duration of the pulses protects the tissues against potential damage from heat generated by continuous fields (Athanasiou 2007) .
Description of the intervention
How the intervention might work
There are several theories that explain how the PEMF may exert its effect on tissue generation and cell proliferation in wound healing. Lee 1993 suggested that PEMF might facilitate the migration of electrically-charged cells involved in repairing the wound area, thereby restoring the metabolic conditions of the healing cells. It has also been proposed that PEMF induces a tiny electrical signal on the injured cell membrane, which initiates a series of physiological effects that include an increase in the number of macrophages and fibroblasts present in the wound, a reduction of the inflammation, and an increased deposition of collagen and fibrin, all of which contribute to the healing process (Markoll 2003) . Other theories suggest that PEMF is associated with the production of free radicals within cells, which mediate intracellular communication (Gordon 2007) . PEMF may exert several biological processes involved in wound healing but the exact mechanism is not clear.
Why it is important to do this review
The lack of response to standard therapies for chronic leg ulcers gives impetus to this review. There are also several anecdotal reports of the beneficial effects of EMT for chronic skin wounds, despite the lack of standardisation of the PEMF devices in terms of type, duration, frequency, intensity and length of exposure. A systematic review to assess the available evidence for EMT on venous leg ulcers is therefore merited.
O B J E C T I V E S
To assess the evidence for the effects of EMT on the healing of venous leg ulcers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs). There was no restriction on the basis of language, date of trial publication or publication status.
Types of participants
Studies that involved people of any age, and in any care setting, described as having a venous leg ulcer were eligible for inclusion. As the method of diagnosis of venous ulceration differed between the trials, and was not always described, it was not possible to apply a standard definition for diagnosis of venous ulcers.
Types of interventions
Any form of electromagnetic therapy (EMT) for healing of venous ulcers compared with sham-EMT, no EMT or other treatments.
Types of outcome measures
Primary outcomes 
Searching other resources
For the second update, we checked the bibliography of the systematic review by McGaughey 2009.
Data collection and analysis
Selection of studies
At least two review authors independently scrutinised the search results. We obtained full reports of articles if, from the initial assessment, they appeared to satisfy the inclusion criteria. We resolved disagreements by discussion between review authors.
Data extraction and management
We included data from studies published in duplicate only once. We extracted and summarised details of eligible studies using a data extraction sheet and made attempts to obtain missing data by contacting authors. A second review author checked data extraction. We extracted the following data:
• design of study;
• inclusion and exclusion criteria; • baseline characteristics (by treatment group);
• intervention details;
• outcome measures used;
• results (by treatment group);
• withdrawals (by treatment group); and • adverse effects.
Assessment of risk of bias in included studies
For this review two review authors independently assessed each included study using the Cochrane Collaboration tool for assessing risk of bias (Higgins 2011). This tool addresses six specific domains, namely sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other issues (e.g. extreme baseline imbalance) (see Appendix 5 for details of the criteria on which the judgement was based). We assessed blinding and completeness of outcome data for each outcome separately. We completed a 'Risk of bias' table for each eligible study and discussed any disagreement amongst all review authors to achieve a consensus. We explicitly judged each of these criteria using the following system: 'Yes' (i.e. low risk of bias); 'No' (i.e. high risk of bias); and 'Unclear' (i.e. either lack of information or uncertainty over the potential for bias). We presented an assessment of risk of bias using a 'Risk of bias' summary figure, which shows all the judgements in a cross-tabulation of study by entry ( Figure 1 ; Figure 2 ). 
Data synthesis
We presented all results quantitatively where possible, and in a narrative summary where there were insufficient data. For each trial with dichotomous outcomes (e.g. were ulcers healed? (yes or no)), we calculated a risk ratio (RR) of healing with 95% confidence intervals. Where outcomes for continuous variables were presented without confidence intervals, standard deviations, or some measure of the precision of the result, we entered the data into the Characteristics of included studies and did not use them in data pooling.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies.
For the third update of the review we identified no new studies that met the inclusion criteria.
Included studies
We included three studies of EMT in the review (Ieran 1990; Kenkre 1996; Stiller 1992) . All studies compared the use of EMT with sham-EMT. They were small, with sample sizes ranging from 19 to 44. All participants were considered to have venous leg ulcers, although none of the studies reported how assessments were conducted. Ieran 1990 recruited 44 people with venous leg ulcers to a doubleblind RCT conducted in Italy. Participants were randomised to receive either EMT (75 Hz, 2.7 mT, with an impulse width 1.3 ms; n = 22) for four hours per day or sham stimulation for the same period of time (n = 22). Patients carried out the stimulation at home. No compression therapy was administered. Oral and local antibiotic therapy was given concomitantly to both groups. The study ran for a three-month period. The outcome measured was the percentage of ulcers healed and the size of wound area at three months. Kenkre 1996 examined the treatment of venous leg ulcers with EMT in a randomised, controlled, double-blind trial based in a leg ulcer clinic in an urban general practice in Birmingham, UK. Nineteen people were randomly allocated into three arms: the first treatment group received 600 Hz electric field, and 25 mT magnetic field, delivered by an Elmedistraal device (which generates perpendicular electric and magnetic fields). The second group received 600 Hz on days one to five, and 800 Hz on days six to 30 from a 25 mT magnetic field, delivered by an Elmedistraal device, for 30 minutes, five days a week for a total of 30 days followed by four weeks' observation. The control group received sham therapy. All participants had ulcer dressings changed by community staff, although there was no standardisation of dressings. All patients were reported to be receiving compression therapy; the authors reported that only two people received "adequate" compression. The primary outcome was the percentage of ulcers healed and changes in the ulcer area at day 50. Healing was based on clinical assessment scores which assessed changes in wound area. Stiller 1992 randomised 31 people into a multi-centre, doubleblind, sham-controlled trial in the USA. Eighteen people randomised to the active treatment group received the following: pulsed EMT (0.06 mV/cm, with a signal which was a three-part pulse [+, -, +] of 3.5 ms total width and a duty cycle of 25%), delivered by a Pulsed Electromagnetic Limb Ulcer Therapy (PELUT) device for three hours a day, plus standard treatment (ancillary topical treatment). Thirteen people were randomised to receive sham-EMT and standard treatment. The groups were treated over an eight-week period, or until the ulcer healed, whichever came first. Treatment continued for 12 weeks for patients who showed a favourable response at eight weeks. Standard treatment consisted of compression bandaging, leg elevation and the use of one of five named dressings. The outcomes measured were percentage change in wound area, mean decrease in wound depth, percentage change in area of granulation tissue, and percentage of ulcers healed or markedly improved at week eight. Wound healing was based on the investigators' clinical global assessment of the healing status which considered wound area, ulcer depth, appearance of granulation and pain. The percentage of ulcers either healed or showing marked improvement was combined and not presented separately in the study report.
Excluded studies
We added two studies, both CCTs, to the table Excluded studies (Jeran 1987; Todd 1991) .
Risk of bias in included studies
Risk of bias in the included studies is summarised in Figure 1 and Figure 2 .
Allocation
For sequence generation, two trials clearly reported adequate randomisation (Ieran 1990; Stiller 1992) , in that participants were randomly distributed to the control or experimental group according to a computer-generated code. While we judged risk of bias due to allocation concealment to be low for Ieran 1990, it was not clear whether allocation was concealed for Stiller 1992. Kenkre 1996 described their study as randomised, however, the methods of sequence generation, as well as allocation concealment, were unclear.
Blinding
All trials were reported as "double-blind." Ieran 1990 and Stiller 1992 described in detail how the active and dummy devices were indistinguishable to patients and investigators; in Kenkre 1996 there was insufficient information on how the participants and outcome assessors were blinded.
Incomplete outcome data
In judging the risk of bias for incomplete outcome reporting, we considered all primary outcome measures; namely, the proportion of wounds healed, and the reduction in wound size and time to complete healing. We also considered whether an intention-totreat (ITT) analysis was reported for the primary outcomes and whether missing data were imputed appropriately. We considered risk of bias due to incomplete outcome data low in Kenkre 1996 and Stiller 1992 . No participants were excluded or lost to follow up in Kenkre 1996, while Stiller 1992 imputed missing data based on the last observed values carried forward and made an estimation by linear extrapolation for the wound size outcome; the imputation results based on these two methods were reported to be in agreement with one another. Ieran 1990 did not conduct an ITT analysis and missing outcome data were slightly more in the EMT group (4/22; 18%) compared to the sham-EMT group (3/22; 14%); risk of bias due to this slight imbalance was thus unclear.
Selective reporting
In judging the risk of bias for selective reporting, we were unable to assess the trial protocols and therefore assessed the studies based on the pre-specified outcome measures reported in the methods section of the trial report. The risk of bias due to selective reporting was considered low for all three trials as all of the pre-specified outcomes were reported.
Other potential sources of bias
Two trials were partly sponsored by the manufacturer of the device (Kenkre 1996; Stiller 1992) . There is evidence that industry-sponsored trials may overestimate the treatment effect (see Bhandari 2004).
Effects of interventions Electromagnetic therapy (EMT) compared with sham therapy Primary outcomes
Number of wounds healed
We did not pool data from Ieran 1990 and Kenkre 1996 because these trials had different treatment durations. Stiller 1992 did not assess this outcome.
Number of wounds healed at 90 days
Ieran 1990 reported that three people in the sham-EMT group (3/22, 14%) and four in the EMT group (4/22, 18%) were lost to follow up. Therefore, 19 people in the sham group and 18 in the EMT group were included in the complete case analysis. Assessment at 90 days found that 12/18 (67%) ulcers had healed in the EMT group compared with 6/19 (32%) in the sham group (RR 2.11; 95% CI 1.01 to 4.42) (Analysis 1.1). The difference between the groups was marginally statistically significant in favour of EMT (P = 0.05), however, this is a small study which did not conduct an intention-to-treat (ITT) analysis and had missing data in each arm. This study was at low to moderate risk of bias overall as aspects of bias, namely sequence generation, allocation concealment and blinding, were adequately achieved.
To assess the potential impact of loss to follow up on effect estimates in Ieran 1990, we considered two assumptions; the worstcase scenario and the best-case scenario. In the worst-case scenario all the people lost to follow up were regarded as treatment failures (wounds not healed), and in the best-case scenario all the losses to follow up were considered as treatment successes (wounds healed). The significance of the results changed with the two assumptions made. In the worst-case scenario, the difference between the groups was found to be not statistically significant (RR 2.00; 95% CI 0.92 to 4.37) (Analysis 2.1) while in the best-case scenario assumption the difference between the groups was shown to be statistically significant (RR 1.78; 95% CI 1.01 to 3.12) (Analysis 3.1).
Number of wounds healed at 50 days
In Kenkre 1996 there was no loss to follow up. We grouped the two EMT treatment arms together. At day 50, 2/10 (20%) venous ulcers were healed in the EMT group compared with 2/9 (22%) in the sham-EMT group (RR 0.90; 95% CI 0.16 to 5.13). The difference between the groups was not statistically significant ( Analysis 4.1). This study was at unclear risk of bias as aspects of bias, namely sequence generation, allocation concealment and blinding, were not clear. Stiller 1992 reported that at eight weeks, 1/18 (6%) in the EMT group and 3/13 people in the sham-EMT group (23%) were lost to follow up (overall 13%). No ulcers healed in the sham group, while 50% of ulcers either healed or showed marked improvement in the EMT group. This outcome was assessed subjectively and 'marked improvement' was not a pre-specified outcome, therefore these data are not included in the analysis. This study was at unclear risk of bias overall.
Reduction in wound size
The results from the three studies for the continuous outcome (reduction in wound size) could not be pooled. No trials reported any evaluation of the precision of the reduction in wound size (change from baseline). It was also not possible to derive missing data from the statistics provided.
Based on complete case analysis in Stiller 1992, the ulcers in the EMT group were reported to decrease in size by 47% at eight weeks, whilst in the sham-EMT group the ulcers increased in size by 49% over the same time period (P value < 0.0002). For the ITT analysis, the wound area at eight weeks of people who discontinued the study was determined by two methods: either by estimation by linear extrapolation to day 56, or by the use of the last observed wound area in place of the eight-week value. The results based on the last observed values were reported to be similar to those based on the extrapolated eight-week values. The EMT group averaged a 48% decrease in wound surface area compared with a 42% increase seen in the sham-EMT group (P value < 0.0002). The ulcers appeared evenly matched for baseline size though ulcers in the sham group were of longer duration (a prognostic factor for time to heal).
Time to complete healing
Ieran 1990 reported the mean healing time but did not express the intervention effect as a hazard ratio which is the most appropriate way of summarizing time-to-event data. Kenkre 1996 and Stiller 1992 did not report on this outcome.
Secondary outcomes
Cost
Assessment of cost was not undertaken in any of the studies.
Quality of life
Quality of life using a validated scale was not measured in any of the studies. Kenkre 1996, however, assessed the mobility of participants and reported that all groups showed increased mobility at trial end.
Pain
All the studies reported pain as a secondary outcome; however, the results of the studies could not be pooled owing to the different scales used to assess pain. Kenkre 1996 used analogue scales (in mm) and reported that at the end of the study, significant reduction in pain scores was only observed for the EMT groups. The analogue scale used to measure pain in Ieran 1990 was not described. At the end of the study, pain was reported to be lower in both the EMT and sham-EMT groups but the difference between the groups was not significant. Stiller 1992 reported pain intensity on a four-point scale where 0 equated to no pain; 1 to mild pain; 2 to moderate pain; and 3 to severe pain. The reduction in pain score was reported to be significantly more for the EMT group.
Acceptability of treatment
Assessment of acceptability of treatment was not undertaken in any of the studies.
Adverse effects
Adverse effects were not reported in Ieran 1990 or Stiller 1992. Kenkre 1996 reported that 13/19 (68%) participants experienced adverse events. Two participants in the EMT group suffered moderate to severe headaches. Sensations of heat, tingling, and pins and needles in the limb were experienced by people in both groups.
D I S C U S S I O N
Three small trials involving a total of 94 patients were included in this review. Whilst one small trial reported significantly more ulcers healing with electromagnetic therapy (EMT) compared with sham-EM, this result was not robust to different assumptions regarding the outcomes of patients lost to follow up. One other trial did not show an effect in favour of EMT while the third trial did not assess the proportions of ulcers healed.
The extent to which the studies were at risk of bias was variable. Two of the three studies lacked clarity about the method of allocation concealment; there is evidence that inadequate allocation concealment leads to an overestimation of the treatment effect (Schulz 2000) . The studies by Kenkre 1996 and Stiller 1992 were at unclear risk of bias overall with the small study by Ieran 1990 at low to moderate risk of bias.
It is important for trials to use more objective measures of treatment success, such as time to complete healing, when assessing interventions in wound trials (Grey 2009). Since the assessment of healing was based on a clinical global assessment in two of the trials, the blinding of the outcome assessor is critical to ensure detection bias has not been introduced. One study was inadequately blinded for investigator-assessed outcomes, even though indistinguishable EMT and sham devices were used (Kenkre 1996).
The methods for handling missing data in the trials varied. Kenkre 1996 did not have any drop-outs. Stiller 1992 imputed missing data using last observation carried forward analysis and estimation by linear extrapolation for wound area, while Ieran 1990 did not carry out ITT analysis. We examined whether the results changed and checked the robustness of the observed findings in Ieran 1990 by performing a worst-case scenario ITT analysis (all the people who dropped out considered as having wounds not healed) and a best-case scenario analysis (all the people who dropped out as having healed ulcers). The results changed with the two assumptions made with the assumption (all loss to follow up as having ulcers healed) showing a significant difference favouring EMT. However, the worst-case scenario assumption is an extreme and in most cases unrealistic assumption (Akl 2009). Nevertheless, our analysis was valuable in demonstrating that the effect estimate in Ieran 1990 did not remain statistically significant under the assumption of a worst-case scenario.
Another concern was that two of the studies were sponsored by the manufacturer of the electromagnetic devices (Kenkre 1996; Stiller 1992), and whilst there is evidence that industry-sponsored trials may overestimate the treatment effect (Bhandari 2004), we were unable to draw any firm conclusions as to whether this has affected the results of these trials.
A U T H O R S ' C O N C L U S I O N S Implications for practice
At present, there is no high quality evidence that electromagnetic therapy (EMT) speeds the healing of venous leg ulcers.
Implications for research
Methodologically sound and robust RCTs are needed in order to investigate further any effect of using EMT to improve venous leg ulcer healing. When reporting these trials, authors should follow the CONSORT statement for reporting controlled trials (CONSORT 2010) so that the trials can be accurately assessed by readers and reviewers. In addition, the procedures for diagnosing venous leg ulcers and the stage of the wound(s) should be described.
Future studies should explore the effects of EMT as an adjunct to optimum treatment with compression, and also as an option for people who cannot tolerate compression or for whom compression is contraindicated.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Ieran 1990
Methods RCT, computer-generated schedule in blocks of 4, double-blind Low risk Quote: "patients were randomly distributed to a control group or experimental group according to a computer generated schedule prepared by a biostatistician"
Allocation concealment (selection bias) Low risk Quote: "the computer generated a list that assigned equal number of active and control stimulators in blocks of four, two active and two dummy units" "Nobody involved in the study was aware of the experimental condition; codes used to include patients in the control and active groups were opened at the end, when all evaluation had been completed" Blinding (performance bias and detection bias) wound healed Low risk Quote: "Nobody involved in the study was aware of the experimental conditions; codes used to include patients in the control or active group were opened at the end, when all evaluation had been completed." "Active and dummy stimulators were absolutely indistinguishable from the outside both for their shape and for their weight."
Blinding (performance bias and detection bias) wound area Low risk Quote: "Nobody involved in the study was aware of the experimental conditions; codes used to include patients in the control or active group were opened at the end, when all evaluation had been completed." "Active and dummy stimulators were absolutely indistinguishable from the outside both for their shape and for their weight" "The pictures taken on each visit were shown to 3 different physicians unaware of the experimental conditions"
Incomplete outcome data (attrition bias) wound healed 
Stiller 1992
Methods RCT, computer-generated randomisation based on order of admittance to study Participants 31 patients with venous leg ulcer. Venous leg ulcer < 7.0 cm diameter; no response to non-surgical treatment in 4 weeks prior to study; ulcer stability (not more than 15% change in diameter, and not more than 15% change in percentage of granulation tissue, in 2 weeks prior to study) 
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding -was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others unlikely to introduce bias.
High risk of bias
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
Were incomplete outcome data adequately addressed?
Low risk of bias
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods. 
High risk of bias
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size.
• 'As-treated' analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided).
• The study did not address this outcome. 
Low risk of bias
Any of the following.
• The study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon)
High risk of bias
• Not all of the study's pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias. 
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D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W
For the review update, we added an additional outcome, adverse effects, to Characteristics of included studies. The review authors judged that collecting data on adverse effects was an acceptable post hoc decision.
